Simcere Pharmaceutical Group Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China. It develops Endostar, a recombinant human endostatin injection; ENWEIDA, an envafolimab injection; Leruiping, a fully human monoclonal antibody targeting IL-4Ra; Zemprocitinib a highly selective JAK1 inhibitor; and Xianlinda, an inhibitor for influenza polymera...
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 86 25 8556 6666
Fax: 86 25 8547 1729
Address:
No. 699-18, Xuanwu Road, Xuanwu District, Nanjing, China
